Product image of Zemplar (Paricalcitol) supplied by GNH India

Zemplar

Active Ingredient:
Paricalcitol
Origin:
EU

Zemplar (Paricalcitol)

Paricalcitol is a vitamin D analog used to manage secondary hyperparathyroidism in chronic kidney disease. This intravenous form helps regulate calcium and phosphorus levels. Commonly prescribed for dialysis patients, it supports bone health. Short-term use under medical supervision is typical.

Manufacturer / TM Owner

Abbvie Ltd (Uk)

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

Indications & Clinical Uses

  • Paricalcitol is primarily used to treat secondary hyperparathyroidism in patients with chronic kidney disease, particularly those on dialysis. It works by reducing elevated parathyroid hormone levels, which can otherwise weaken bones over time. The medication is often prescribed when dietary adjustments and phosphate binders alone are insufficient. It may also be considered for patients not yet on dialysis but with significant parathyroid hormone elevation.

Side Effects

  • Paricalcitol helps balance calcium and phosphorus levels in the blood, which supports overall bone health. Patients may experience improved energy levels and reduced symptoms related to high parathyroid hormone, such as bone pain or muscle weakness. Some individuals notice gradual normalization of lab values over time with consistent use.

Precautions & Warnings

  • Store paricalcitol in a cool, dry place away from direct light. Keep out of reach of children and pets. If the solution appears discolored or contains particles, do not use it. Always check the expiration date before administration. Discard any unused medication as directed by a healthcare provider.

Avoid Interactions

  • Paricalcitol may interact with other medications that affect calcium or vitamin D levels, such as thiazide diuretics or calcium supplements. High doses of calcium or phosphate binders can increase the risk of hypercalcemia. Inform your healthcare provider about all medications, including over-the-counter products and supplements, before starting paricalcitol.

Frequently Asked Questions

Paricalcitol is used to treat secondary hyperparathyroidism in patients with chronic kidney disease.

Paricalcitol is given as an intravenous injection, typically by a healthcare professional.

Some patients may experience mild side effects like nausea or headache, but these vary by individual.

Consult a healthcare provider before using paricalcitol if pregnant or breastfeeding.

Paricalcitol is available by prescription; consult a licensed pharmacy or healthcare provider for availability.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Paricalcitol

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT